EQBK vs EXAS · P/E 40, rev $215.8M vs rev $2.76B
Equity Bancshares, Inc. (EQBK) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Equity Bancshares, Inc. (EQBK) is a banks - regional company listed on NYSE.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported EQBK revenue for 2026-06-30 was $215.8M. Net income was $43.4M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. EQBK currently screens at market cap $974.3M and trailing P/E 40.0.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
EQBK currently screens at market cap $974.3M and trailing P/E 40.0. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the EQBK and EXAS stock pages for the full models.
Not investment advice.